CARLSBAD, Calif. and CAMBRIDGE, Mass., Sept. 26, 2018 /PRNewswire/ -- DCN Dx, a developer and manufacturer of rapid point-of-care diagnostic tests, and E25Bio, an MIT-spinoff diagnostics company from ...

Martis Capital has made an investment in Carlsbad, California-based DCN Dx, a lateral flow diagnostics developer. No financial terms were disclosed. Pegasus Capital and TM Capital advised on the ...

BERKELEY, Calif. and MAINZ, Germany, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the ...

MOORESTOWN, N.J., June 17, 2021 /PRNewswire/ — DCN Dx, an international provider of point-of-care diagnostics development, products, and educational programming, today announced it has completed its ...

CARLSBAD, Calif., July 26, 2013 /PRNewswire/ --DCN Diagnostics(formerly Diagnostic Consulting Network) and Asahi Kasei Fibers Corporation(AKFC) announce a new partnership based around AKFC's patented ...

CARLSBAD, Calif., July 17, 2025 /PRNewswire/ -- DCN Dx, a specialist in lateral flow diagnostics development, manufacturing, and IVD regulatory consulting and clinical research, will exhibit at ADLM ...

DCN Dx, based in Carlsbad, California, is a global leader in IVD CDMO and CRO services. Our multidisciplinary team specializes in creating tailored assay systems, consumables, and instruments for ...

LA JOLLA, Calif., April 30, 2025 /PRNewswire/ -- The Advanced Lateral Flow Conference (ALFC) is now accepting applications for poster presentations at its 2025 event, taking place October 14-15, 2025, ...

CARLSBAD, Calif., Oct. 1, 2024 /PRNewswire/ -- DCN Dx, a global leader in diagnostic development and clinical research services, is excited to announce its participation in the 2024 IDWeek Annual ...

MOORESTOWN, N.J., June 17, 2021 /PRNewswire/ — DCN Dx, an international provider of point-of-care diagnostics development, products, and educational programming, today announced it has completed its ...